Journal article icon

Journal article

Exploiting the defensive sugars of HIV-1 for drug and vaccine design

Abstract:
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antigens on the virus's surface. Intriguingly, however, recent findings suggest that these carbohydrates, which have evolved to protect HIV and promote its transmission, are also attractive therapeutic targets.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1038/nature05818

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Role:
Author


Publisher:
Nature Research
Journal:
Nature More from this journal
Volume:
446
Issue:
7139
Pages:
1038-1045
Publication date:
2007-04-25
DOI:
EISSN:
1476-4687
ISSN:
0028-0836


Language:
English
Keywords:
Pubs id:
pubs:99986
UUID:
uuid:c9ecb654-9f7e-4df8-a61c-f60f9af76d17
Local pid:
pubs:99986
Source identifiers:
99986
Deposit date:
2012-12-19

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP